切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (06) : 539 -543. doi: 10.3877/cma.j.issn.2095-3232.2021.06.001

所属专题: 综述

述评

肝叶增生促进技术在剩余肝体积不足肝切除中的应用
曹磊1, 廖明恒1, 曾勇1,()   
  1. 1. 610041 成都,四川大学华西医院肝脏外科及肝移植中心
  • 收稿日期:2021-09-02 出版日期:2021-09-23
  • 通信作者: 曾勇

Liver regeneration inducing techniques in hepatectomy with insufficient future liver remnant

Lei Cao1, Mingheng Liao1, Yong Zeng1()   

  • Received:2021-09-02 Published:2021-09-23
  • Corresponding author: Yong Zeng
引用本文:

曹磊, 廖明恒, 曾勇. 肝叶增生促进技术在剩余肝体积不足肝切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(06): 539-543.

Lei Cao, Mingheng Liao, Yong Zeng. Liver regeneration inducing techniques in hepatectomy with insufficient future liver remnant[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(06): 539-543.

[1]
Lim KC, Chow PK, Allen JC, et al. Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria[J]. Br J Surg, 2012, 99(12):1622-1629.
[2]
Stiles Zachary E, Behrman Stephen W, Glazer Evan S, et al. Predictors and implications of unplanned conversion during minimally invasive hepatectomy: an analysis of the ACS-NSQIP database[J]. HPB, 2017, 19(11):957-965.
[3]
Kong Z, Hu J, Ge X, et al. Preserving hepatic artery flow during portal triad blood occlusion improves regeneration of the remnant liver in rats with obstructive jaundice following partial hepatectomy[J]. Exp Ther Med, 2018, 16(3):1910-1918.
[4]
Shindoh J, Tzeng CWD, Vauthey J. Portal vein embolization for hepatocellular carcinoma[J]. Liver Cancer, 2012, 1(3/4): 159-167.
[5]
Aoki T, Kubota K. Preoperative portal vein embolization for hepatocellular carcinoma: consensus and controversy[J]. World J Hepatology, 2016, 8(9):439-445.
[6]
Aussilhou B, Lesurtel M, Sauvanet A, et al. Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant[J]. J Gastrointestinal Surg, 2008, 12(2):297-303.
[7]
Capussotti L, Muratore A, Baracchi F, et al. Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases[J]. Arch Surg, 2008, 143(10):978-982.
[8]
Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy:a planned strategy to treat irresectable liver tumors[J]. Ann Surg, 2000, 232(6):777-785.
[9]
Imai K, Allard M, Benitez C, et al. Early recurrence after hepatectomy for colorectal liver metastases: what optimal definition and what predictive factors?[J]. Oncologist, 2016, 21(7):887-894.
[10]
de Santibañes E, Clavien P. Playing play-doh to prevent postoperative liver failure: the "ALPPS" approach[J]. Ann Surg, 2012, 255(3):415-417.
[11]
Schnitzbauer Andreas A, Lang Sven A, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings[J]. Ann Surg, 2012, 255(3):405-414.
[12]
Petrowsky H, Györi G, de Oliveira M, et al. Is partial-ALPPS safer than ALPPS? a single-center experience[J]. Ann Surg, 2015, 261(4): e90-92.
[13]
de Santibañes E, Alvarez FA, Ardiles V, et al. Inverting the ALPPS paradigm by minimizing first stage impact: the mini-ALPPS technique[J]. Langenbecks Arch Surg, 2016, 401(4):557-563.
[14]
Robles R, Parrilla P, López-Conesa A, et al. Tourniquet modification of the associating liver partition and portal ligation for staged hepatectomy procedure[J]. Br J Surg, 2014, 101(9):1129-1134.
[15]
Gringeri E, Boetto R, D'Amico FE, et al. Laparoscopic microwave ablation and portal vein ligation for staged hepatectomy (LAPS): a minimally invasive first-step approach[J]. Ann Surg, 2015, 261(2): 42-43.
[16]
Gall TMH, Sodergren MH, Frampton AE, et al. Radio-frequency-assisted liver partition with portal vein ligation (RALPP) for liver regeneration[J]. Ann Surg, 2015, 261(2):45-46.
[17]
Hwang S, Lee SG, Ko GY, et al. Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy[J]. Ann Surg, 2009, 249(4):608-616.
[18]
Hwang S, Ha TY, Ko GY, et al. Preoperative sequential portal and hepatic vein embolization in patients with hepatobiliary malignancy[J]. World J Surg, 2015, 39(12):2990-2998.
[19]
Munene G, Parker RD, Larrigan J, et al. Sequential preoperative hepatic vein embolization after portal vein embolization for extended left hepatectomy in colorectal liver metastases[J]. World J Surg Oncol, 2013(11):134.
[20]
Guiu B, Chevallier P, Denys A, et al. Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique[J]. Eur Radiol, 2016, 26(12): 4259-4267.
[21]
Ogata S, Belghiti J, Farges O, et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma[J]. Br J Surg, 2006, 93(9):1091-1098.
[22]
Knoefel WT, Gabor I, Rehders A, et al. In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection[J]. Br J Surg, 2013, 100(3):388-394.
[23]
Shindoh J, Vauthey JN, Zimmitti G, et al. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach[J]. J Am Coll Surg, 2013, 217(1):126-133.
[24]
Croome KP, Hernandez-Alejandro R, Parker M, et al. Is the liver kinetic growth rate in ALPPS unprecedented when compared with PVE and living donor liver transplant? a multicentre analysis[J]. HPB, 2015, 17(6):477-484.
[25]
Schadde E, Hernandez-Alejandro R, Lang H, et al. ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors. results of a multicentre analysis: reply[J]. World J Surg, 2015, 39(7):1510-1519.
[26]
Tanaka K, Matsuo K, Murakami T, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): short-term outcome, functional changes in the future liver remnant, and tumor growth activity[J]. European J Surg Oncol, 2015, 41(4):506-512.
[27]
Ratti F, Schadde E, Masetti M, et al. Strategies to increase resectability of patients with colorectal liver metastases: a multi-center case-match analysis of ALPPS versus conventional two-stage hepatectomy[J]. Ann Surg Oncol, 2015, 22(6):1933-1942.
[28]
Matsuo K, Murakami T, Kawaguchi D, et al. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization[J]. Surgery, 2016, 159(5):1289-1298.
[29]
Schindl MJ, Redhead DN, Fearon KC, et al. The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection[J]. Gut, 2005, 54(2):289-296.
[30]
崔宏,高琴琴,王效益, 等. 肝细胞癌合并肝硬化患者肝切除术后标准残肝体积评估[J]. 中国现代普通外科进展, 2019, 22(4):296-299.
[31]
Truant S, Oberlin O, Sergent G, et al. Remnant liver volume to body weight ratio > or =0.5%: a new cut-off to estimate postoperative risks after extended resection in noncirrhotic liver[J]. J Am Coll Surg, 2007, 204(1):22-33.
[32]
Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry[J]. Ann Surg, 2009, 250(4):540-548.
[33]
李富贵,严律南,曾勇, 等. 中国成人标准肝体积评估公式的临床研究[J]. 四川大学学报(医学版), 2009, 40(2):302-306.
[34]
陈熙,杜正贵,李波, 等. 标准残肝体积对肝脏储备功能的评价[J]. 世界华人消化杂志, 2010, 18(17):1829-1833.
[35]
Kamiyama T, Kakisaka T, Orimo T, et al. Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus[J]. World J Hepatol, 2017, 9(36):1296-1304.
[36]
Wang Z, Peng Y, Hu J, et al. Associating liver partition and portal vein ligation for staged hepatectomy for unresectable hepatitis B virus-related hepatocellular carcinoma: a single center study of45 patients[J]. Ann Surg, 2020, 271(3):534-541.
[37]
李健,文张,徐邦浩,等. 联合门静脉切除重建的ALPPS治疗肝内胆管细胞癌[J/OL]. 中华肝脏外科手术学电子杂志, 2020, 9(1):62-66.
[1] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[2] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[5] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[6] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[7] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[8] 胡森焱, 徐冬, 方健, 谢冬冬, 王财庆. ICG荧光显影Laennec膜入路腹腔镜解剖性肝切除的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 513-516.
[9] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[10] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[11] 陆镜明, 韩大为, 任耀星, 黄天笑, 向俊西, 张谞丰, 吕毅, 王傅民. 基于术前影像组学的肝内胆管细胞癌淋巴结转移预测的系统性分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 852-858.
[12] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[13] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[14] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
[15] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
阅读次数
全文


摘要